[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100635150":3},{"organization":4,"armGroups":7,"interventions":8,"overallOfficials":15,"centralContacts":20,"locations":26,"responsibleParty":41,"collaborators":7,"id":43,"slug":7,"hasResults":44,"nctId":45,"briefTitle":46,"officialTitle":47,"acronym":48,"eligibilityCriteria":49,"healthyVolunteers":44,"sex":50,"minAge":51,"maxAge":7,"enrollmentInfo":52,"targetDuration":7,"studyType":55,"phases":7,"briefSummary":56,"conditions":57,"keywords":61,"overallStatus":28,"whyStopped":7,"lastUpdateSubmitDate":70,"lastUpdatePostDateStruct":71,"startDateStruct":74,"completionDateStruct":76,"leadSponsor":78,"locationsCount":79},{"fullName":5,"class":6},"Okuvision GmbH","INDUSTRY",null,[9],{"type":10,"name":11,"description":12,"armGroupLabels":7,"otherNames":13},"DEVICE","Transcorneal Electrical Stimulation using the OkuStim System","Single application of the OkuStim® System for TES therapy in accordance with its intended purpose for 30 minutes.\n\nNo control or comparative intervention planned.",[14],"OkuStim",[16],{"name":17,"affiliation":18,"role":19},"Dr. med. Svenja Deuchler","Augenzentrum Frankfurt Prof. Koch GmbH","PRINCIPAL_INVESTIGATOR",[21],{"name":22,"role":23,"phone":24,"phoneExt":7,"email":25},"Claudia Büdel","CONTACT","+49 69 7566 8880","info@azffm.de",[27],{"facility":18,"status":28,"city":29,"state":7,"zip":30,"country":31,"cosmosGeoPoint":32,"geoPoint":37,"contacts":38},"RECRUITING","Frankfurt am Main","60549","Germany",{"type":33,"coordinates":34},"Point",[35,36],8.68417,50.11552,{"lat":36,"lon":35},[39,40],{"name":22,"role":23,"phone":24,"phoneExt":7,"email":25},{"name":17,"role":19,"phone":7,"phoneExt":7,"email":7},{"type":42,"investigatorFullName":7,"investigatorTitle":7,"investigatorAffiliation":7,"oldNameTitle":7,"oldOrganization":7},"SPONSOR","100635150",false,"NCT07548944","Observational Study to Investigate the Short-term Effects of Transcorneal Electrical Stimulation on Visual Performance","Observational Study to Investigate the Short-term Effects of Transcorneal Electrical Stimulation (TES) on Visual Performance in Patients With Retinitis Pigmentosa and Similar Retinal Diseases","TES-STEP","Inclusion Criteria:\n\n* Adult patients (≥ 18 years) with clinically diagnosed retinitis pigmentosa (RP) or other similar degenerative retinal disease\n* Current treatment with TES using the OkuStim® System within the intended purpose\n* Subjective perception of short-term effects after TES treatment\n* Ability and willingness to give informed consent\n\nExclusion Criteria:\n\n* Cognitive, psychological, or linguistic limitations that prevent informed consent or proper study participation\n* Presence of other eye diseases (e.g., cataract, glaucoma, macular degeneration) that, in the opinion of the investigator, compromise or confound study assessments\n* Simultaneous participation in other clinical studies that could influence the results of the study\n* Severe comorbidities that could compromise patient safety or study conduct","ALL","18 Years",{"count":53,"type":54},30,"ESTIMATED","OBSERVATIONAL","Retinitis pigmentosa and similar degenerative diseases of the retina lead to progressive loss of vision. TES therapy with the CE-marked OkuStim® System is a treatment approved in the EU for slowing the progression of the disease. Patients increasingly report short-term subjective improvements in vision, which have not yet been systematically investigated. This exploratory study is conducted to determine whether these subjective short-term effects can be measured, and therefore also be quantified, by objective tests.",[58,59,60],"Retinitis Pigmentosa (RP)","Usher Syndrome","Cone Rod Dystrophy",[62,63,14,64,65,66,67,68,69],"Transcorneal Electrical Stimulation","TES","Okuvision","Retinitis pigmentosa","Eye Diseases","Retinal Dystrophies","Retinal Degeneration","Retinal Diseases","2026-04-30",{"date":72,"type":73},"2026-05-01","ACTUAL",{"date":75,"type":73},"2026-04-20",{"date":77,"type":54},"2027-03",{"name":5,"class":6},1]